Welcome to the international HTA database

Showing [24040 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Vincristine liposomal (Marqibo) in combination with chemotherapy for elderly patients with newly diagnosed CD20 positive diffuse large B-cell lymphoma – first line
2015	Scottish Health Technologies Group (SHTG)	Antimicrobial wound dressings (AWDs) for chronic wounds: Health technology assessment report 13
2015	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	ROX Coupler for treatment-resistant hypertension
2015	NIHR Health Technology Assessment programme	Vortioxetine for treating major depressive disorder
2015	NIHR Public Health Research (PHR) programme	Analysis of lower limb movement to determine the effect of manipulating the appearance of stairs to improve safety: a linked series of laboratory-based, repeated measures studies
2015	HAYES, Inc.	Nucleus hybrid L24 cochlear implant system (Cochlear Limited) for hearing loss
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Eprodisate disodium (Kiacta) for AA amyloidosis
2015	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	STAR tumour ablation system
2015	NIHR Health Services and Delivery Research programme	Geographical understanding of variation in place of death: the role of care services and end of life care improvement (GUIDE_Care Services)
2015	HAYES, Inc.	Pulsed Electromagnetic Field (PEMF) therapy for treatment of postoperative knee pain and edema
2015	NIHR Horizon Scanning Centre (NIHR HSC)	STG 320 for allergic rhinitis
2015	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Microwave ablation for liver tumours
2015	NIHR Health Services and Delivery Research programme	Impact of a change to remuneration on the technical efficiency of dental practices: evaluation of the pilots of a new NHS Dental Contract in Northern Ireland
2015	HAYES, Inc.	Tandem autologous stem cell transplant for Hodgkin lymphoma
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Cerliponase alfa for neuronal ceroid lipofuscinosis type 2 (CLN2 disease)
2015	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	ViewRay System for MRI guided radiotherapy
2015	NIHR Health Technology Assessment programme	Evaluation and validation of social and psychological markers in randomised trials of complex interventions in mental health: a methodological research programme
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Pridopidine (Huntexil) for Huntington's disease
2015	Belgian Health Care Knowledge Centre (KCE)	Percutaneous vertebroplasty and balloon kyphoplasty
2015	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	InSpace biodegradable subacromial spacer for the treatment of rotator cuff tears
2015	NIHR Health Services and Delivery Research programme	What are the determinants of variations in emergency readmission rates and one-year mortality in patients hospitalized with heart failure or chronic obstructive pulmonary disease?
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Percutaneous Mitral Valve Repair System (MitraClip®) for mitral valve insufficiency]
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Aflibercept solution (Eylea) for visual impairment due to choroidal neovascularisation secondary to pathological myopia
2015	Belgian Health Care Knowledge Centre (KCE)	Cervical and lumbar total disc replacements
2015	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Bioresorbable vascular scaffolds
2015	NIHR Health Technology Assessment programme	Calculating when elective abdominal aortic aneurysm repair improves survival for individual patients: development of the Aneurysm Repair Decision Aid and economic evaluation
2015	Agency for Healthcare Research and Quality (AHRQ)	Use of cardiac resynchronization therapy in the Medicare population
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Deep brain stimulation for Parkinson's disease]
2015	NIHR Horizon Scanning Centre (NIHR HSC)	rhNGF for neurotrophic keratitis – first line
2015	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Transcatheter mitral valve replacement for severe mitral regurgitation
2015	NIHR Health Technology Assessment programme	Developing and piloting a peer mentoring intervention to reduce teenage pregnancy in looked-after children and care leavers: an exploratory randomised controlled trial
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Intracorneal rings for patients with keratoconus]
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Abatacept for psoriatic arthritis – second line
2015	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Optical coherence tomography (OCT) for retinal assessment in the presence of diabetic macular oedema (DMO) for access to treatment with dexamethasone posterior segment drug delivery system
2015	NIHR Health Technology Assessment programme	Bronchiolitis of Infancy Discharge Study (BIDS): a multicentre, parallel-group, double-blind, randomised controlled, equivalence trial with economic evaluation
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Ki-67 proliferative index in patients with early breast cancer]
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Bimagrumab for sporadic inclusion body myositis – first line
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Teduglutide for the treatment of patients with short bowel syndrome]
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Remestemcel-L (Prochymal) for steroid refractory acute graft versus host disease – second line
2015	Andalusian Health Technology Assessment Area (AETSA)	[Balloon eustachian tuboplasty for the treatment of eustachian tube dysfunction]
2015	NIHR Public Health Research (PHR) programme	Employer schemes to encourage walking to work: feasibility study incorporating an exploratory randomised controlled trial
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Deep brain stimulation in patients with treatment-resistant depressive disorder, obsessive compulsive disorder and Tourette syndrome]
2015	Andalusian Health Technology Assessment Area (AETSA)	[Selection criteria for direct antiviral agents for patients with chronic hepatitis c in the SSPA]
2015	NIHR Health Technology Assessment programme	Use of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicentre, placebo-controlled, randomised controlled trial and cost-effectiveness analysis of a calcium channel blocker (nifedipine) and an alpha-blocker (tamsulosin) (the SUSPEND trial)
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Algisyl-LVR implantable hydrogel (biopolymer) for advanced heart failure
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Genomic expression tests in patients with breast cancer: MammaPrint®, Oncotype DX® and Prosigna®]
2015	NIHR Health Technology Assessment programme	The TOMMY trial: a comparison of TOMosynthesis with digital MammographY in the UK NHS Breast Screening Programme - a multicentre retrospective reading study comparing the diagnostic performance of digital breast tomosynthesis and digital mammography with digital mammography alone
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Insulin infusion pumps for diabetic patients]
2015	Andalusian Health Technology Assessment Area (AETSA)	[Simeprevir in the treatment of chronic hepatitis C. Comparative efficacy and safety assessment]
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Belimumab for the treatment of Systemic Lupus Erythematosus]
2015	NIHR Health Technology Assessment programme	Clinical effectiveness and cost-effectiveness of open and arthroscopic rotator cuff repair (the UK Rotator Cuff Surgery (UKUFF) randomised trial)
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Ranibizumab (Lucentis) for choroidal neovascularisation and macular oedema
2015	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[PET-CT: needs assessment for planning]
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Denosumab for the treatment of solid tumor bone metástasis]
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Fractional flow reserve in coronary artery]
2015	NIHR Health Technology Assessment programme	UK DRAFFT: a randomised controlled trial of percutaneous fixation with Kirschner wires versus volar locking-plate fixation in the treatment of adult patients with a dorsally displaced fracture of the distal radius
2015	NIHR Horizon Scanning Centre (NIHR HSC)	CoSense® End Tidal Carbon Monoxide monitor for neonatal haemolytic disease
2015	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Hadron therapy in children: evidence synthesis for 15 paediatric tumours. Report based on Belgian (KCE) HTA report]
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Porcine biological prosthesis for the management of anal fistula]
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Corneal collagen crosslinking with riboflavin for keratoconus patients]
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Idarucizumab for the reversal of anticoagulation due to treatment with dabigatran – first line
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Sofosbuvir and simeprevir-based schemes for the management of hepatitis C]
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Asunaprevir, beclabuvir and daclatasvir fixed dose combination for hepatitis C virus infection, genotype 1 – first or second line
2015	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Nonoperative correction of pectus carinatum with orthotic bracing]
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Raltegravir for the treatment of human immunodeficiency virus infection]
2015	NIHR Health Technology Assessment programme	What is the clinical effectiveness and cost-effectiveness of conservative interventions for tendinopathy? An overview of systematic reviews of clinical effectiveness and systematic review of economic evaluations
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Sofosbuvir (Sovaldi) with GS-5816 for chronic hepatitis C
2015	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Radiofrequency ablation for Barrett´s esophagus with high-grade dysplasia or intramucosal cancer: a systematic review]
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Ombitasvir, paritaprevir and ritonavir regimens in hepatitis C patients]
2015	NIHR Health Technology Assessment programme	Clinical effectiveness of elemental nutrition for the maintenance of remission in Crohn's disease: a systematic review and meta-analysis
2015	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Efficiency, effectiveness and safety of mechanical ventricular assistance with HeartWare® device in terminal heart failure]
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Ceritinib for the treatment of ALK-positive metastatic non-small cell lung cancer]
2015	NIHR Health Technology Assessment programme	Effectiveness and economic evaluation of self-help educational materials for the prevention of smoking relapse: randomised controlled trial
2015	NIHR Health Technology Assessment programme	The use of measures of obesity in childhood for predicting obesity and the development of obesity-related diseases in adulthood: a systematic review and meta-analysis
2015	NIHR Horizon Scanning Centre (NIHR HSC)	Epratuzumab for systemic lupus erythematosus
2015	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Clinical effectiveness of newborn screening for inborn errors of metabolism using mass spectrometry. Part IV: Beta-kethiolase deficiency (BKT); 3-Hydroxy-3-methyl glutaric aciduria (HMG)]
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Vitamin D screening in adults]
2015	NIHR Health Technology Assessment programme	Individual cognitive stimulation therapy for dementia: a clinical effectiveness and cost-effectiveness pragmatic, multicentre, randomised controlled trial
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Cabazitaxel, abiraterone and enzalutamide in metastatic castration-resistant prostate cancer not responding to docetaxel]
2015	Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)	[Care models of pharmaceutical provision in health and social care centres]
2015	NIHR Health Technology Assessment programme	A study of cellular counting to determine minimum thresholds for adequacy for liquid-based cervical cytology using a survey and counting protocol
2015	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Darunavir (Prezista®)
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Tecar therapy for the management of osteoarticular lesions]
2015	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Levonorgestrel (Jaydess®)
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Dynamic magnetic resonance imaging for focal liver lesion assessment]
2015	NIHR Health Technology Assessment programme	The Clots in Legs Or sTockings after Stroke (CLOTS) 3 trial: a randomised controlled trial to determine whether or not intermittent pneumatic compression reduces the risk of post-stroke deep vein thrombosis and to estimate its cost-effectiveness
2015	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Avanafil (Spedra®)
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Intra-articular hyaluronic acid (viscosupplementation) in osteoarthritis]
2015	NIHR Health Technology Assessment programme	Interventions to treat premature ejaculation: a systematic review short report
2015	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Regorafenib (Stivarga®)
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Cognitive rehabilitation in cognitive deficit secondary to stroke]
2015	Institut national d'excellence en sante et en services sociaux (INESSS)	[Efficacy of intraoperative radiation therapy]
2015	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Peginterferon beta-1a (Plegridy®)
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Omalizumab for the management of asthma]
2015	NIHR Health Technology Assessment programme	A scoping study to explore the cost-effectiveness of next-generation sequencing compared with traditional genetic testing for the diagnosis of learning disabilities in children
2015	Institut national d'excellence en sante et en services sociaux (INESSS)	[Assisted reproduction]
2015	NIHR Health Services and Delivery Research programme	Development, validation and evaluation of an instrument for active monitoring of men with clinically localised prostate cancer: systematic review, cohort studies and qualitative study
2015	Institute for Clinical Effectiveness and Health Policy (IECS)	[Usefulness of the ALCAT test in food intolerance]
2015	NIHR Health Technology Assessment programme	Prasugrel (Efient®) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis
2015	Institut national d'excellence en sante et en services sociaux (INESSS)	[Development framework for social services practice guidelines]